This provides up to an additional $11,375 beyond the standard DRG payment for the procedure, according to a news relese. It’s available at facilities that provide inpatient care for spinal stenosis and spondylolisthesis.
The TOPS System earned the FDA’s breakthrough technology designation in 2020 and granted PMA approval in June. The system is an alternative to lumbar spinal fusion for patients with spinal stenosis and spondylolisthesis.
Recent data supported the cost-effectiveness of the system.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
